Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Fformat: Artigo
Iaith:Russo
Cyhoeddwyd: «FIRMA «SILICEA» LLC 2004-12-01
Cyfres:Российский кардиологический журнал
Pynciau:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
Mynediad Ar-lein:https://russjcardiol.elpub.ru/jour/article/view/2326
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg